The heads are finally starting to roll in commercial real estate. And another $200 billion of office mortgages remain outstanding and will need to be refinanced before the end of 2026. This could turn out much worse than the subprime-lending fiasco from 2007.
It’s commonly believed that Warren Buffett doesn’t buy tech stocks. But, as Porter writes today, that’s not true. In fact, Buffett’s largest personal investment was once into a start-up tech business.
First a supply-chain bottleneck, then a warehouse fire, sent this hugely popular, non-brick-and-mortar company’s revenue plunging. It has fought its way back and now finds itself on solid ground once again.
While corporate insiders and Wall Street analysts wave the caution flag by selling way more than buying, retail investors have never been more euphoric. We look at how that plays out across The Big Secret portfolio.
What the arrest of my friend, an extravagant, big-spending real estate broker, has to do with the next big financial crisis.
This morning, uniQure (Nasdaq: QURE) – which we originally recommended as part of our basket of 10 negative-EV stocks in January with an entry price of $6.62, and recommended again as a standalone pick in October with an entry price of $4.54 – issued a press release announcing that the company has reached an agreement
The finance-industrial complex is not happy about memecoins. Or more to the point, that 18 year-old kids are minting small, and not-so-small, fortunes by speculating on worthless assets. In today’s Daily Journal, we discuss what this means under a Trump administration.
In today’s Daily Journal, Porter explains his evolution as an investor – and why value investing is a dead end, and what’s replaced it for him.
In this issue, analyst Erez Kalir focuses on a Big Picture inflection point that he says is crucially important for biotech holdings as well as every other investment in an investor’s portfolio.
U.S. equity funds have experienced more inflows of capital than any prior year on record – and four times as much as is going into non-U.S. equities. The divergence is creating a big buying opportunity.